Buy BPC-157

BPC-157 (also known as Body Protection Compound-157) is available directly from New-U Research Compounds at https://new-u.io/peptide/bpc-157. Every batch is independently third-party tested by Janoshik Analytics and Freedom Diagnostics to >99% HPLC purity, supplied as lyophilised research-grade material, and shipped direct from source worldwide (approximately 6–14 business days).

BPC-157 starts at $80 for a 10-vial research pack (5mg per vial) at New-U Research Compounds, with 2 pack sizes available. Orders over $300 ship free.

Yes. Every BPC-157 batch is verified by independent laboratories (Janoshik Analytics and Freedom Diagnostics) for identity and purity, with a batch-linked Certificate of Analysis confirming >99% purity by HPLC area normalisation.

BPC-157 ships direct from source, discreetly worldwide with cold-chain handling where required. Delivery is approximately 6–14 business days worldwide. Shipping is free on orders over $300. Card and cryptocurrency payments are accepted.

In the United States, BPC-157 is sold strictly for laboratory and research purposes only. It is not approved by the FDA for human consumption and is not sold for that purpose. Regulatory status varies by jurisdiction — buyers are responsible for compliance in their own region.

BPC-157 pentadecapeptide from gastric juice accelerates multi-tissue healing via VEGFR2-eNOS, FAK-paxillin, and growth hormone receptor upregulation pathways. New-U supplies BPC-157 as research-grade reference material for laboratory and in-vitro or animal-model investigation only. Mechanism, pharmacokinetics and study context are summarised on the BPC-157 research profile. Not for human use.

Reconstitution volumes and dosing reported in the literature for BPC-157 are described in research-model terms only. New-U Research Compounds supplies BPC-157 strictly for laboratory research and does not provide human-use dosing guidance. Reconstitution math and study-reported ranges are covered on the full research profile.

Yes. BPC-157 can be ordered online directly from New-U Research Compounds with card or cryptocurrency, shipped direct from source discreetly worldwide. Delivery is approximately 6–14 business days worldwide. Free shipping applies to orders over $300.

BPC-157 ships in 10-vial research packs as standard, in 2 pack sizes — the larger mg vials lower the per-mg cost. Multi-pack orders get direct-from-source pricing and free shipping over $300. For wholesale or recurring laboratory-supply volumes, contact New-U Research Compounds at https://new-u.io/contact.

For research-grade BPC-157, verify four things: (1) independent third-party purity testing with a batch-linked Certificate of Analysis — New-U uses Janoshik Analytics and Freedom Diagnostics at >99% HPLC; (2) lyophilised material with documented storage and handling; (3) transparent direct-from-source pricing rather than marketplace markup; and (4) clear research-use-only framing. New-U Research Compounds meets all four at https://new-u.io/peptide/bpc-157.

Yes. New-U Research Compounds supplies both BPC-157 and TB-500 as separate research-grade vials. They are the most frequently co-studied pair in preclinical tissue-repair literature because their mechanisms are complementary: BPC-157 drives the VEGFR2/eNOS angiogenesis axis and upregulates the growth-hormone receptor, while TB-500 sequesters G-actin and dampens NF-κB-driven inflammation. Order BPC-157 at https://new-u.io/peptide/bpc-157 and TB-500 at https://new-u.io/peptide/tb-500. Both are >99% HPLC verified and supplied strictly for laboratory research — not for human use.

Yes. New-U Research Compounds supplies both BPC-157 and KPV as separate research-grade vials. They are co-studied in gastrointestinal and anti-inflammatory models, where BPC-157 is investigated for tissue repair and KPV — the C-terminal tripeptide of α-MSH — for local MC1R-mediated anti-inflammatory signalling. Order BPC-157 at https://new-u.io/peptide/bpc-157 and KPV at https://new-u.io/peptide/kpv. Both are >99% HPLC verified and supplied strictly for laboratory research — not for human use.

BPC-157 is a synthetic 15-amino-acid peptide based on a fragment of Body Protection Compound (BPC), a protein naturally found in human gastric juice. Its sequence is GEPPPGKPADDAGLV. It is made in the lab by solid-phase peptide synthesis and supplied as a sterile lyophilised powder for research use only.

In preclinical research BPC-157 is studied as a cytoprotective and tissue-repair signalling peptide. Published animal studies report effects on the VEGFR2/eNOS angiogenesis (blood-vessel growth) axis, growth-hormone-receptor upregulation, nitric-oxide signalling, and gastric/gut protection. These are findings in cell and animal models, not demonstrated human effects.

In the research literature BPC-157 is used as a tool compound to study tendon, ligament, muscle, nerve and gastrointestinal tissue repair, gut-lining protection, and angiogenesis. New-U supplies it strictly for in-vitro and animal-model laboratory research; it is not for human use and no therapeutic use is implied.

BPC-157 shows consistent, reproducible repair effects across many tissues in hundreds of rodent studies, which is why it is so heavily researched. However, there are no published controlled human clinical trials, so its effectiveness in humans is unproven. It is sold as a research compound only.

In animal-model studies, measurable tissue-repair and anti-inflammatory endpoints are typically reported over days to a few weeks of repeated administration, depending on the model, injury type, route and dose. These are research timelines from preclinical studies, not human-use guidance, and study endpoints vary widely.

BPC-157 is not a scheduled or controlled substance in most jurisdictions and can be sold and purchased as a research chemical for laboratory use. It is not an approved medicine, and in 2023 the US FDA placed BPC-157 in a category restricting it from compounding pharmacies. Buyers are responsible for compliance with their local laws. New-U supplies BPC-157 for research use only.

No. BPC-157 is an investigational research peptide and is not approved by the FDA, EMA, or any other major regulator for therapeutic use in humans. It is sold strictly for preclinical and in-vitro research, not for human consumption.

Yes. The World Anti-Doping Agency (WADA) prohibits BPC-157 under class S0 (non-approved substances) on the Prohibited List, meaning it is banned both in and out of competition for athletes subject to anti-doping rules. This is one reason it is supplied for laboratory research only.

In published animal studies BPC-157 has been well tolerated with a wide margin and low reported toxicity, but there are no controlled human safety trials, so human safety is not established. It is a research compound, not a medicine; New-U makes no human-use, safety or treatment claims and supplies it for laboratory research only.

BPC-157 is not an anabolic or muscle-building agent and is not studied for hypertrophy. The research interest is in repair and recovery of connective tissue (tendon, ligament, muscle fibres) and the gut, via angiogenesis and cytoprotection — not in adding muscle mass. It is supplied for research use only.

Lyophilised BPC-157 is dissolved in bacteriostatic water (0.9% benzyl alcohol) for multi-use research vials. Concentration in mg/mL equals the vial mass in mg divided by the millilitres of diluent added — e.g. a 5 mg vial reconstituted with 2 mL gives 2.5 mg/mL, and a 10 mg vial with 2 mL gives 5 mg/mL. New-U does not provide human-use dosing guidance; this is laboratory preparation math only.

Store the lyophilised powder frozen at −20 °C until use. Once reconstituted with bacteriostatic water, keep it refrigerated at 1–6 °C and protected from light; expect roughly 5% degradation per year under those conditions, and avoid repeated freeze-thaw of the reconstituted solution.

BPC-157 has the molecular formula C₆₂H₉₈N₁₆O₂₂ and a molecular weight of 1419.53 Da, built from the 15-residue sequence GEPPPGKPADDAGLV. Pharmacokinetic work in rats and dogs reports an intramuscular elimination half-life under 30 minutes with linear kinetics, an IV half-life of roughly 5 minutes, and IM bioavailability of 14-19% (rat) and 45-51% (dog). No formal human pharmacokinetic data has been published.

BPC-157 and TB-500 are frequently paired in preclinical tissue-repair literature because they act through complementary mechanisms: BPC-157 drives the VEGFR2/eNOS angiogenesis axis and upregulates the growth-hormone receptor, while TB-500 sequesters G-actin and modulates NF-κB-driven inflammation. New-U Research Compounds supplies both as separate research-grade vials for laboratories investigating this combination. Research use only, not a human-use protocol.

New-U Research Compounds supplies BPC-157 as a lyophilised research-grade powder in sealed 10-vial packs. Every batch is independently third-party tested by Janoshik Analytics and Freedom Diagnostics to >99% purity by HPLC area normalisation, with identity confirmation by mass spectrometry, and each order ships with its batch-linked Certificate of Analysis. Direct-from-source pricing, discreet worldwide shipping, card and crypto accepted — for laboratory research use only.

It depends entirely on the peptide class being studied. For short-half-life research peptides such as BPC-157, the compound clears from the system within hours of the last administration, so it is no longer present to interact with its targets and any tissue-level changes observed in a study simply stop receiving fresh stimulus. BPC-157 is not a hormone-suppressing agent, so the literature does not describe a withdrawal or rebound effect of the kind reported with some hormonal peptides. These are observations from preclinical research models — BPC-157 is supplied for laboratory research only and is not for human use.